Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERL: Allopurinol for GFR Loss in T1D
NCT02017171Phase 3Completed
- Sponsor
- Alessandro Doria
- Start
- Feb 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of allopurinol in diabetic nephropathy (DN), sponsored by Alessandro Doria. Started Feb 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02017171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017171.